Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Chubb
Citi
Julphar
QuintilesIMS
AstraZeneca
Daiichi Sankyo
Teva
Mallinckrodt

Generated: April 24, 2018

DrugPatentWatch Database Preview

DISOMER Drug Profile

« Back to Dashboard

Which patents cover Disomer, and when can generic versions of Disomer launch?

Disomer is a drug marketed by Schering and is included in one NDA.

The generic ingredient in DISOMER is dexbrompheniramine maleate. There are seven drug master file entries for this compound. Additional details are available on the dexbrompheniramine maleate profile page.
Drug patent expirations by year for DISOMER
Synonyms for DISOMER
( )-(3-p-Bromphenyl-3-pyrid-2'-ylpropyl)dimethylamin
( )-N,N-Dimethyl-(3-(4-bromphenyl)-3-(2-pyridyl)propyl)amin
(+)-(3-p-Bromphenyl-3-pyrid-2'-ylpropyl)dimethylamin
(+)-2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate
(+)-2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate (1:1)
(+)-2-(p-bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine maleate
(+)-3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine maleate
(+)-3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine maleate
(+)-3-(p-bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine maleate
(+)-Brompheniramine
(+)-Brompheniramine maleate
(+)-Brompheniramine maleate salt
(+)-brompheniraminum
(+)-N,N-Dimethyl-(3-(4-bromphenyl)-3-(2-pyridyl)propyl)amin
(+)-Parabromdylamine
(|AS)-|A-(4-bromophenyl)-N,N-dimethyl-2-pyridinepropanamine (2Z)-2-Butenedioate
(3-p-Bromphenyl-3-pyrid-2'-ylpropyl)dimethylamin
(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine; maleic acid
(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine
(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine (2Z)-but-2-enedioate
(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine maleate
(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine
(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine; (Z)-but-2-enedioic acid
(R)-3-(4-Bromophenyl)-3-(2-pyridyl)propyldimethylamine
(S)-(+)-brompheniramine
(S)-1-(p-bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane maleate
(S)-2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridinium (Z)-maleate (1:1)
(S)-2-(p-bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine maleate
(S)-2-[p-Bromo-|A-[2-(dimethylamino)ethyl]benzyl]pyridine Maleate
(S)-3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine maleate
(S)-3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine maleate
(S)-3-(p-bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine maleate
(S)-brompheniramine
(S)-Brompheniramine Maleate
[(3S)-3-(4-bromophenyl)-3-(pyridin-2-yl)propyl]dimethylamine
1-(p-Bromophenyl)-1-(2-pyridyl)-3-dimethylamine Propane Maleate
132-21-8
2-Pyridinepropanamine, .gamma.-(4-bromophenyl)-N,N-dimethyl-, (.gamma.S)-, (2Z)-2-butenedioate (1:1)
2-Pyridinepropanamine, .gamma.-(4-bromophenyl)-N,N-dimethyl-, (S)-
2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-, (S)-, (Z)-2-butenedioate (1:1)
2391-03-9
3-(4-bromophenyl)- N,N-dimethyl- 3-pyridin-2-yl-propan-1-amine
3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine #
75T64B71RP
AB00698453-08
AC-1161
AC1L291B
AC1O5G0Y
AC1Q2610
AKOS015962824
AKOS015969654
Alahist IR
Alahist PE
AN-15187
B 5275
BC214876
Bio-0009
BPA9UT29BS
Brompheniramine d-
Brompheniramine d-form maleate
C-23708
C20H23BrN2O4
CAS-2391-03-9
CC-26370
CCG-101017
CCG-204327
CHEBI:59269
CHEBI:59273
CHEMBL1200638
CHEMBL1201287
CPD000471616
d-2-[p-Bromo-|A-(2-dimethylaminoethyl)benzyl]pyridine Maleate
D-Brompheniramine
d-Brompheniramine maleate
D02WIW
D03704
DB00405
Desbrofeniramina
Dexbromfeniramina
Dexbromfeniramina [INN-Spanish]
Dexbrompheniramin
Dexbrompheniramine
Dexbrompheniramine [INN:BAN]
Dexbrompheniramine fumarate
DEXBROMPHENIRAMINE MALEATE
Dexbrompheniramine maleate (USAN)
Dexbrompheniramine maleate [USP]
Dexbrompheniramine maleate, United States Pharmacopeia (USP) Reference Standard
DEXBROMPHENIRAMINEMALEATE
Dexbrompheniraminum
Dexbrompheniraminum [INN-Latin]
Dimegan
Disomer (TN)
Disomer maleate
DR001403
Drixoral
DSSTox_CID_27795
DSSTox_GSID_47818
DSSTox_RID_82567
DTXSID6047818
DTXSID8022905
EINECS 205-053-5
EINECS 219-236-2
EU-0100232
FT-0772799
GTPL7588
Halin
HE068442
HE288008
HE306570
HMS2051F10
HMS2235O07
HMS3260P05
Lopac0_000232
LP00232
LS-172813
MLS001401374
N,N-Dimethyl-(3-(4-bromphenyl)-3-(2-pyridyl)propyl)amin
NC00267
NCGC00015146-11
NCGC00093697-01
NCGC00162100-01
NCGC00162100-02
NCGC00162100-03
NCGC00260917-01
Parabromodylamine
PDSP1_000134
PDSP1_000135
PDSP2_000133
PDSP2_000134
Pyridine, 2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)-, maleate (1:1), (S)-
Pyridine, 2-[p-bromo-.alpha.-[2-(dimethylamino)ethyl]benzyl]-, (S)-
SAM001246556
SCHEMBL217770
SCHEMBL29345
SMR000471616
Tox21_112000
Tox21_112000_1
Tox21_500232
UNII-75T64B71RP
UNII-BPA9UT29BS
UNII-H57G17P2FN component ZDIGNSYAACHWNL-HNNXBMFYSA-N
UNII-IXA7C9ZN03 component SRGKFVAASLQVBO-DASCVMRKSA-N
W0027
ZDIGNSYAACHWNL-HNNXBMFYSA-N
ZINC96

US Patents and Regulatory Information for DISOMER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering DISOMER dexbrompheniramine maleate SYRUP;ORAL 011814-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering DISOMER dexbrompheniramine maleate TABLET;ORAL 011814-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Express Scripts
Citi
Baxter
Julphar
AstraZeneca
UBS
Harvard Business School
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.